We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9898:HKEXWeibo Corp Class A Analysis

Data as of 2026-03-17 - not real-time

HK$77.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Weibo Corp (9898.HK) trades at a trailing PE of about 5.6, dramatically below the industry average of 17.9, and a price‑to‑book of 0.61, suggesting a deep valuation discount. The stock also offers an 8.2% dividend yield with a moderate payout ratio of 47%, backed by net cash of roughly HKD 2.0 bn after accounting for debt. However, revenue is contracting (‑4.8% YoY) and operating cash flow is flat, highlighting short‑term earnings pressure. The technical picture shows a bearish trend with price below the 20‑day SMA (77.9) and near the computed support of 73.8, while the MACD line has turned slightly bullish and the RSI sits at 44, indicating limited upside momentum.
Market sentiment is currently in an “Extreme Greed” phase (fear‑greed index 79.45), but the stock’s high volatility (≈26% 30‑day) and low beta (~0.18) suggest price swings are driven more by company‑specific factors than broader market moves. Regulatory risk in China’s internet sector remains high, and geographic concentration adds to the risk profile, yet the combination of a strong dividend, attractive valuation, and a solid cash buffer supports a cautiously optimistic stance for medium‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Upcoming Q4/FY2025 earnings release on March 18
  • Current price near technical support with bearish trend
  • High dividend yield providing income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount relative to peers
  • Sustainable dividend and strong cash position
  • Potential recovery in advertising spend as market stabilises

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistent regulatory and geopolitical uncertainties in China
  • Stable dividend income supporting total return
  • Valuation buffer mitigating downside risk

Key Metrics & Analysis

Financial Health

Revenue Growth-4.80%
Profit Margin26.58%
P/E Ratio5.6
ROE12.37%
ROA4.54%
Debt/Equity47.28
P/B Ratio0.6
Industry P/E17.9

Technical Analysis

TrendBearish
RSI44.8
SupportHK$73.80
ResistanceHK$81.15
MA 20HK$77.90
MA 50HK$81.14
MA 200HK$82.87
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Target PriceHK$90.74
Upside/Downside17.31%
GradeUndervalued
TypeValue
Dividend Yield8.21%

Risk Assessment

Beta0.25
Volatility26.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.